Chongqing Dongze Medicine

Chongqing Dongze Pharmaceutical is a pharmaceutical company based in Chongqing, China, and operates as a wholly-owned subsidiary of Chongqing Pharscin Pharmaceutical (002907.SZ). The company is primarily responsible for the commercialization, wholesale, and distribution of the Pharscin Group's extensive portfolio of chemical drugs and traditional Chinese medicines. Its therapeutic focus includes gastroenterology, cardiology, respiratory diseases, and anti-infectives. Dongze plays a vital role in the group's integrated business model, which encompasses research and development, GMP-certified manufacturing, and a robust sales network. The company's product line features both innovative drugs, such as potassium-competitive acid blockers, and a wide array of high-quality generic preparations. By leveraging Pharscin's R&D capabilities, Dongze ensures the delivery of essential treatments to the Chinese healthcare market.